Organogenesis Holdings Inc. Operating Income

Quick Answer

Organogenesis Holdings Inc. reported Operating Income of $44.69 million for fiscal year 2025.

Organogenesis Holdings Inc. Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 $44.69M +3583.6%
2024 -$1.28M -110.2%
2023 $12.53M -43.8%
2022 $22.30M -69.1%
2021 $72.22M +170.5%
2020 $26.70M +189.4%
2019 -$29.85M +42.1%
2018 -$51.56M -838.4%
2017 -$5.49M +37.4%
2016 -$8.78M -34774.0%
2015 -$25.2K

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 $20.73M +232.1% +264.8%
June 30, 2025 -$12.58M +9.5% +53.0%
March 31, 2025 -$26.75M -594.3% -528.5%
September 30, 2024 $6.24M -22.5% +144.9%
June 30, 2024 -$13.89M -242.6% -260.6%
March 31, 2024 -$3.85M +3.7% -147.9%
September 30, 2023 $8.05M +352.5% -17.4%
June 30, 2023 $9.74M -18.3% +343.6%
  • Organogenesis Holdings Inc. showed an increase of +3583.6% in Operating Income compared to the prior fiscal year.
  • Over the 2015–2025 period, Organogenesis Holdings Inc.’s operating income has grown by 177725.0% (from -$25.2 thousand to $44.69 million).
  • The most recent figure is from Organogenesis Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment